APA

Merenstein D., Murphy M., Fokar A., Hernandez R. K., Park H., Nsouli H., Sanders M. E., Davis B. A., Niborski V., Tondu F. & Shara N. M. (20110113). Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. : European journal of clinical nutrition.

Chicago

Merenstein D, Murphy M, Fokar A, Hernandez R K, Park H, Nsouli H, Sanders M E, Davis B A, Niborski V, Tondu F and Shara N M. 20110113. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. : European journal of clinical nutrition.

Harvard

Merenstein D., Murphy M., Fokar A., Hernandez R. K., Park H., Nsouli H., Sanders M. E., Davis B. A., Niborski V., Tondu F. and Shara N. M. (20110113). Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. : European journal of clinical nutrition.

MLA

Merenstein D, Murphy M, Fokar A, Hernandez R K, Park H, Nsouli H, Sanders M E, Davis B A, Niborski V, Tondu F and Shara N M. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. : European journal of clinical nutrition. 20110113.